Clinical trial
The Role of Intralipid in Natural Killer Cell Positive Cases With Recurrent Miscarriages Undergoing IVF/ICSI Cycles: a Double Blind Randomized Controlled Trial
NCT01788540 is registered in ClinicalTrials.gov with Woman's Health University Hospital, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Intralipid in Natural Killer Cell Positive Cases With Recurrent Miscarriages Undergoing IVF/ICSI Cycles: a Double Blind Randomized Controlled Trial
- Lead sponsor
- Woman's Health University Hospital, Egypt
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- September 30, 2016
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.